The discovery that thymic epithelium from many species expresses a large repertoire of genes encoding neuroendocrine and other tissuerestricted antigens has radically changed our knowledge of the pathogenic mechanisms underlying the development of organ-specific autoimmune diseases such as type 1 diabetes and autoimmune endocrine diseases. Rather than a breakdown of immunological selftolerance in periphery, there is mounting evidence that the diabetogenic autoimmune response may first arise from a thymus dysfunction in the central programming of β-cell self-tolerance. Insulin-like growth factor 2 (IGF-2) is the dominant member of the insulin gene/protein family expressed in thymic epithelial cells (TECs) from different species, and Igf2 -/-mice fail to programme complete tolerance to insulin.
In distant species and invertebrates, the foundations of the neuroendocrine and immune systems have co-existed until now without any apparent problem. Some 470 millions years ago, while gene conversion already determined some rudiments of immune diversity in primitive vertebrates (such as jawless fishes), adaptive immunity emerged in lymphoid cells of cartilaginous fishes (i.e. sharks and rays). Adaptive immune response is characterised by enzymatic machinery specialising in the random recombination of gene segments encoding the variable parts of B-cell receptor (BCR) and T-cell receptor (TCR) for antigens. The emergence of this sophisticated defence system exerted a very potent pressure for the appearance of lymphoid structures and pathways necessary to impose immunological self-tolerance, i.e. the inability of the immune system to react against the host organism. The first thymus appeared in cartilaginous fishes concomitantly or very shortly after adaptive immunity. This organ is not an endocrine gland, but it stands at the crucial intersection between the immune and neuroendocrine systems.
1 Among all lymphoid tissues, the thymus is unique in that it is the only place where there is a permanent confrontation between ancient, almost constant, neuroendocrine principles and a more recently evolved system equipped with machinery that stochastically generates diversity of the adaptive immune response. The progressive rise in the level of immune diversity and complexity may explain why failures in self-tolerance (systemic and organ-specific autoimmune diseases) are increasingly detected during evolution, with most such failures observed in the human species. Because the intrathymic education is so complex, mistakes easily occur, leading to thymic output of self-reactive T lymphocytes orientated against components of the neuroendocrine system and other peripheral tissues. Contrary to the assumption that has prevailed for a very long time, the thymus operates throughout life, and it plays a fundamental role in generating the peripheral repertoire of T lymphocytes that are diverse, selftolerant and competent against non-self antigens.
Thymus Physiology and the Nature of 'Neuroendocrine Self' • Neuroendocrine self-antigens usually correspond to peptide sequences that have been the most conserved throughout the evolution of a given family.
• Some hierarchy characterises their expression profile in the thymus. This hierarchy in the organisation of the thymic repertoire of neuroendocrine self-antigens is also significant from an evolutionary point of view. As discussed above, some physiological and essential functions emerged before the development of adaptive immunity had to be protected from its inherent risk of autotoxicity. Therefore, OT as a peptide, implicated at different steps of reproductive biology and thus in species preservation, had to be protected to a greater degree than vasopressin (VP), which essentially controls water metabolism.
Also, IGF-2 as a major growth factor in foetal development had to be protected to a greater extent than insulin, which is responsible for Ins and Igf1 transcripts were detected in all thymi from BB-DP and BB-DR rats. Igf2 transcripts were also present in the thymus from all BB-DR rats, but were absent in the thymus from more than 80% of BB-DP rats, in close concordance with the incidence of autoimmune diabetes in those rats (86%). 
During whole life, the thymus generates effector T cells (Teff) that are competent against non-self antigens and self-tolerant, as well as self-specific natural regulatory T cells (Treg). Thymic epithelium is the site of expression for many genes encoding neuroendocrine selfantigens and tissue-restricted antigens. The AIRE gene controls transcription of most of those genes. Self-antigen expression in the thymus intervenes both in negative selection of self-reactive T cells and in positive selection of self-antigen specific natural Treg. Absence of or decrease in thymic self-antigen expression as observed in several animal models of autoimmunity will lead to the enrichment of the peripheral pool with self-reactive T cells, while generation of self-antigen-specific natural
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